Brean Murray Upgrades Palomar Medical (PMTI) to Buy; JNJ Pullout Creates Buying Opportunity
More News related to JNJ
- ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities
- StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc.
- Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
- Trading Outlook for BioElectronics Corporation Issued by StockPreacher.com
- LecTec Corporation and Endo Pharmaceuticals Inc. Settle Patent Dispute
More News related to PMTI
- New! The Groove Optic(TM) for the Lux2940(TM): A Breakthrough in Fractional Skin Resurfacing
- Palomar Medical Reports Financial Results for Third Quarter 2009
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- Garth Fisher, M.D.(R), F.A.C.S., Announces Adoption of LifeSculpt Body Sculpting Within His World-Renowned Plastic Surgery Practice
- Palomar Medical Technologies To Host Third Quarter 2009 Financial Results Conference Call and Webcast on October 29, 2009
Brean Murray upgrades Palomar Medical (Nasdaq: PMTI) to Buy. Price target $18.
Brean analyst says, "Johnson&Johnson (NYSE: JNJ) withdrawal not a complete disappointment; Entry point offers more positive long-term opportunities."
To see more analyst ratings on PMTI Click Here.
Palomar Medical Technologies, Inc., along with its subsidiaries, designs, manufactures, markets, and sells lasers and other light-based products, and related disposable items and accessories for use in medical and cosmetic procedures.
Related Categories
UpgradesStocks Mentioned
+0.38
-0.06Related Entities
Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
FUTURE ERNINGS
ALTH on Oct 20, 2009 06:29 AMHOW WILL MY SHARES MAKE MONEY ON THIS STOCK?